Literature DB >> 16907856

Expression profiling of apoptosis-related genes in enterocytes isolated from patients with ulcerative colitis.

Jakob B Seidelin1, Ole H Nielsen.   

Abstract

Apoptosis regulation has been implicated as a main cause of epithelial dysfunction in patients with ulcerative colitis. Apoptosis can be divided into distinct pathways, which depend on the expression of a large number of apoptosis-related genes. The aim was to elucidate which pathways are dominant in normal and inflamed colonic epithelial cells. An apoptosis-specific gene array expression profiling system of 96 genes was used to determine the expression profile of apoptosis-related genes. Epithelial cells isolated from three patients with active ulcerative colitis were pooled and compared to pooled epithelial cells isolated from three control subjects. Genes found to be three-fold or more overexpressed in ulcerative colitis were subsequently analysed by PCR in a larger population (10 patients with ulcerative colitis, 8 control subjects). Selected genes found not to be regulated were additionally tested by PCR in the same population. Six genes were found to be highly expressed in epithelial cells from both controls and ulcerative colitis patients. These included Bcl-2 antagonist/killer, B lymphoid tyrosine kinase, caspase 14, Harakiri, tumour necrosis factor (TNF) receptor 2, and TNF receptor-associated factor 1 (TRAF1). Three genes were found to be upregulated in ulcerative colitis (p<0.01): caspase 1 and 5, and inhibitor of apoptosis protein 2 (c-IAP2). Both receptor- and mitochondrion-dependent apoptosis pathways are well expressed in enterocytes. Mainly activation-dependent and cytoprotective genes were upregulated in ulcerative colitis.

Entities:  

Mesh:

Year:  2006        PMID: 16907856     DOI: 10.1111/j.1600-0463.2006.apm_116.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  10 in total

Review 1.  The future of molecular approaches to inflammatory bowel disease.

Authors:  Boyko Kabakchiev; Smita Halder; Mark S Silverberg
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

2.  Caspase 14 does not influence intestinal epithelial cell differentiation.

Authors:  J Benedict Seidelin; J Sträter; O Haagen Nielsen
Journal:  Cell Death Differ       Date:  2013-01-04       Impact factor: 15.828

3.  Protective pathways against colitis mediated by appendicitis and appendectomy.

Authors:  R Cheluvappa; A S Luo; C Palmer; M C Grimm
Journal:  Clin Exp Immunol       Date:  2011-06-27       Impact factor: 4.330

Review 4.  Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.

Authors:  Dylan K McDaniel; Kristin Eden; Veronica M Ringel; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

5.  Upregulation of cIAP2 in regenerating colonocytes in ulcerative colitis.

Authors:  Jakob B Seidelin; Ben Vainer; Lars Andresen; Ole H Nielsen
Journal:  Virchows Arch       Date:  2007-10-31       Impact factor: 4.064

Review 6.  Protease inhibition as new therapeutic strategy for GI diseases.

Authors:  Nathalie Vergnolle
Journal:  Gut       Date:  2016-04-12       Impact factor: 23.059

7.  Evidence for impaired CARD15 signalling in Crohn's disease without disease linked variants.

Authors:  Jakob Benedict Seidelin; Oliver Jay Broom; Jørgen Olsen; Ole Haagen Nielsen
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

8.  Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytes.

Authors:  Kenneth H Mellits; Ian F Connerton; Michael F Loughlin; Peter Clarke; Julie Smith; Eleanor Dillon; Phillippa L Connerton; Francis Mulholland; Christopher J Hawkey
Journal:  BMC Microbiol       Date:  2009-02-04       Impact factor: 3.605

Review 9.  Caspase-14 reveals its secrets.

Authors:  Geertrui Denecker; Petra Ovaere; Peter Vandenabeele; Wim Declercq
Journal:  J Cell Biol       Date:  2008-02-04       Impact factor: 10.539

10.  Tanshinol alleviates ulcerative colitis by promoting the expression of VLDLR.

Authors:  Huanhuan Zhu; Shaopeng Tong; Yan Cui; Xiaodong Wang; Minying Wang
Journal:  Drug Dev Res       Date:  2021-06-18       Impact factor: 5.004

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.